A Class of Sulfonamides with Strong Inhibitory Action against the α-Carbonic Anhydrase from Trypanosoma cruzi

被引:55
作者
Guzel-Akdemir, Ozlen [1 ]
Akdemir, Atilla [2 ]
Pan, Peiwen [3 ,4 ,5 ]
Vermelho, Alane B. [6 ]
Parkkila, Seppo [3 ,4 ,5 ]
Scozzafava, Andrea [7 ]
Capasso, Clemente [8 ]
Supuran, Claudiu T. [7 ,9 ]
机构
[1] Istanbul Univ, Fac Pharm, Dept Pharmaceut Chem, TR-34116 Istanbul, Turkey
[2] Bezmialem Vakif Univ, Fac Pharm, Dept Pharmacol, Istanbul, Turkey
[3] Univ Tampere, Sch Med, Fimlab Ltd, Inst Biomed Technol, Tampere 33520, Finland
[4] Univ Tampere, BioMediTech, Tampere 33520, Finland
[5] Tampere Univ Hosp, Tampere 33520, Finland
[6] Univ Fed Rio de Janeiro UFRJ, Lab Proteases Microrganismos, Inst Microbiol Paulo de Goes, CCS,Ilha Fundao, Rio De Janeiro, RJ, Brazil
[7] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy
[8] CNR, Ist Biochim Prot, I-80131 Naples, Italy
[9] Univ Florence, NEUROFARBA Dept, Sez Sci Farmaceut, I-50019 Florence, Italy
基金
芬兰科学院;
关键词
DRUG DISCOVERY; PATENT; CAH-4B;
D O I
10.1021/jm400418p
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Trypanosoma cruzi, the causative agent of Chagas disease, encodes for an alpha-carbonic anhydrase (CA, EC 4.2.1.1) possessing high catalytic activity (TcCA) which was recently characterized (Pan et al. J. Med. Chem. 2013, 56, 1761-1771). A new class of sulfonamides possessing low nanomolar/subnanomolar TcCA inhibitory activity is described here. Aromatic/heterocydic sulfonamides incorporating halogeno/methoxyphenacetamido tails inhibited TcCA with K(I)s in the range of 0.5-12.5 nM, being less effective against the human off-target isoforms hCA I and II. A homology model of TcCA helped us to rationalize the excellent inhibition profile of these compounds against the protozoan enzyme, a putative new antitrypanosoma drug target. These compounds were ineffective antitrypanosomal agents in vivo due to penetrability problems of these highly polar molecules that possess sulfonamide moieties.
引用
收藏
页码:5773 / 5781
页数:9
相关论文
共 32 条
[1]   Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms? [J].
Alterio, Vincenzo ;
Di Fiore, Anna ;
D'Ambrosio, Katia ;
Supuran, Claudiu T. ;
De Simone, Giuseppina .
CHEMICAL REVIEWS, 2012, 112 (08) :4421-4468
[2]   The first example of a significant active site conformational rearrangement in a carbonic anhydrase-inhibitor adduct: the carbonic anhydrase I-topiramate complex [J].
Alterio, Vincenzo ;
Monti, Simona Maria ;
Truppo, Emanuela ;
Pedone, Carlo ;
Supuran, Claudiu T. ;
De Simone, Giuseppina .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2010, 8 (15) :3528-3533
[3]   Anti-infective carbonic anhydrase inhibitors: a patent and literature review [J].
Capasso, Clemente ;
Supuran, Claudiu T. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (06) :693-704
[4]   Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations [J].
Carta, Fabrizio ;
Aggarwal, Mayank ;
Maresca, Alfonso ;
Scozzafava, Andrea ;
McKenna, Robert ;
Supuran, Claudiu T. .
CHEMICAL COMMUNICATIONS, 2012, 48 (13) :1868-1870
[5]   Novel therapies for glaucoma: a patent review 2007-2011 [J].
Carta, Fabrizio ;
Supuran, Claudiu T. ;
Scozzafava, Andrea .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2012, 22 (01) :79-88
[6]   Carbonic anhydrase inhibitors: Water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects [J].
Casini, A ;
Scozzafava, A ;
Mincione, F ;
Menabuoni, L ;
Ilies, MA ;
Supuran, CT .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (25) :4884-4892
[7]   Chagas disease. What is known and what should be improved: a systemic review [J].
Coura, Jose Rodrigues ;
Borges-Pereira, Jose .
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2012, 45 (03) :286-296
[8]   Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of N-substituted benzenesulfonamides to human isoform II [J].
Di Fiore, Anna ;
Maresca, Alfonso ;
Alterio, Vincenzo ;
Supuran, Claudiu T. ;
De Simone, Giuseppina .
CHEMICAL COMMUNICATIONS, 2011, 47 (42) :11636-11638
[9]   A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology [J].
Fabrizi, Francesca ;
Mincione, Francesco ;
Somma, Teresa ;
Scozzafava, Gabriele ;
Galassi, Fernando ;
Masini, Emanuela ;
Impagnatiello, Francesco ;
Supuran, Claudiu T. .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2012, 27 (01) :138-147
[10]   Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB [J].
Guzel, Ozlen ;
Innocenti, Alessio ;
Scozzafava, Andrea ;
Salman, Aydin ;
Supuran, Claudiu T. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (14) :4894-4899